Zheng Ming-Jie, Wang Jue, Xu Lu, Zha Xiao-Ming, Zhao Yi, Ling Li-Jun, Wang Shui
Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, 210029, Nanjing, China.
Med Oncol. 2015 Feb;32(2):427. doi: 10.1007/s12032-014-0427-4. Epub 2015 Jan 9.
During the past decades, many efforts have been made in mimicking the clinical progress of human cancer in mouse models. Previously, we developed a human breast tissue-derived (HB) mouse model. Theoretically, it may mimic the interactions between "species-specific" mammary microenvironment of human origin and human breast cancer cells. However, detailed evidences are absent. The present study (in vivo, cellular, and molecular experiments) was designed to explore the regulatory role of human mammary microenvironment in the progress of human breast cancer cells. Subcutaneous (SUB), mammary fat pad (MFP), and HB mouse models were developed for in vivo comparisons. Then, the orthotopic tumor masses from three different mouse models were collected for primary culture. Finally, the biology of primary cultured human breast cancer cells was compared by cellular and molecular experiments. Results of in vivo mouse models indicated that human breast cancer cells grew better in human mammary microenvironment. Cellular and molecular experiments confirmed that primary cultured human breast cancer cells from HB mouse model showed a better proliferative and anti-apoptotic biology than those from SUB to MFP mouse models. Meanwhile, primary cultured human breast cancer cells from HB mouse model also obtained the migratory and invasive biology for "species-specific" tissue metastasis to human tissues. Comprehensive analyses suggest that "species-specific" mammary microenvironment of human origin better regulates the biology of human breast cancer cells in our humanized mouse model of breast cancer, which is more consistent with the clinical progress of human breast cancer.
在过去几十年中,人们在小鼠模型中模拟人类癌症临床进展方面做出了许多努力。此前,我们开发了一种源自人乳腺组织(HB)的小鼠模型。理论上,它可能模拟源自人类的“物种特异性”乳腺微环境与人类乳腺癌细胞之间的相互作用。然而,缺乏详细证据。本研究(体内、细胞和分子实验)旨在探讨人类乳腺微环境在人类乳腺癌细胞进展中的调节作用。开发了皮下(SUB)、乳腺脂肪垫(MFP)和HB小鼠模型用于体内比较。然后,收集来自三种不同小鼠模型的原位肿瘤块进行原代培养。最后,通过细胞和分子实验比较原代培养的人类乳腺癌细胞的生物学特性。体内小鼠模型的结果表明,人类乳腺癌细胞在人类乳腺微环境中生长得更好。细胞和分子实验证实,与来自SUB到MFP小鼠模型的细胞相比,来自HB小鼠模型的原代培养人类乳腺癌细胞表现出更好的增殖和抗凋亡生物学特性。同时,来自HB小鼠模型的原代培养人类乳腺癌细胞还获得了向人类组织进行“物种特异性”组织转移的迁移和侵袭生物学特性。综合分析表明,在我们的人源化乳腺癌小鼠模型中,源自人类的“物种特异性”乳腺微环境能更好地调节人类乳腺癌细胞的生物学特性,这与人类乳腺癌的临床进展更为一致。